Predicción y previsión de precio de Cybin Inc (HELP)HELPCybin Inc

Alphio's HELP stock price prediction model matches the current Cybin Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.41 (+2.20%). The 1-week path is $11.12 (+9.09%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Helus Pharma (HELP) is not a good buy due to its declining price and negative financial performance. The stock is trading at $10.55, down 10.59% over the last five days and 14.71% over the last 20 days. The RSI is at 39.353, indicating bearish momentum. Furthermore, the company has reported significant net losses, with a net income of -46,995,000 CAD in Q4 2026, which raises concerns about its financial health. The main risk is the declining stock price, which has dropped from a recent high of $15.15 to its current level, reflecting a loss of investor confidence despite positive analyst ratings. Therefore, it is advisable to sell or hold off on buying until there are signs of recovery in both price and financial performance.

Cybin Inc (HELP) last closed at $10.19, losing -2.95%. These facts feed the 1-day and 1-week HELP price prediction above.